(Bloomberg) -- The Philippines said Johnson & Johnson's Covid-19 vaccine suspension won't affect ongoing supply negotiations.
“The operational pause of J&J is somewhat similar to what happened to other vaccines to ensure public safety and enhance administration protocols,” Philippine vaccine czar Carlito Galvez said in a mobile-phone reply to questions.
The Philippine government has signed an agreement for the supply of 10 million Sputnik V vaccine doses from Russia's Gamaleya National Center of Epidemiology and Microbiology, Galvez said.
Meanwhile, the nation's Food and Drug Administration has recommended to resume the use of AstraZeneca Plc.'s Covid-19 vaccines on persons below 60 years old, its head Eric Domingo said. Blood clotting incidents are “very rare,” he said.
©2021 Bloomberg L.P.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
